Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
7 hedge funds and large institutions have $343K invested in Counterpath Corp in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
42% less capital invested
Capital invested by funds: $594K → $343K (-$251K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$21.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$50.8K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$809 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$767 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$50 |
CPAH Hedge Fund Activity: Q4 2018 in Review
7 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q4 2018, worth a combined $343K — down 42% from $594K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CPAH positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.2K. The largest seller was Fidelity International, cutting an estimated $50.8K.
- 7 institutional investors held Counterpath Corp (CPAH) as of Q4 2018, up from 6 in Q3 2018.
- Funds reported $343K of Counterpath Corp stock for Q4 2018, down 42% quarter-over-quarter.
- 1 fund opened new Counterpath Corp positions in Q4 2018 and 0 closed out, a net change of +1 holder.
- The largest Counterpath Corp buyer in Q4 2018 was Citadel Advisors, an estimated $21.2K added.
- The largest Counterpath Corp seller in Q4 2018 was Fidelity International, an estimated $50.8K sold.
Based on aggregated 13F filings for Q4 2018.